Method to prevent accelerated atherosclerosis using (sRAGE) soluble receptor for advanced glycation endproducts
US7101838B2 · kind B2 · utility
35Cited by
4References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 5, 1997 |
| Grant date | Sep 5, 2006 |
| Priority date | — |
| Expiry date | Aug 5, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides for a method to prevent accelerated atherosclerosis in a subject predisposed thereto which comprises administering to the subject a polypeptide derived from soluble receptor for advanced glycation endproduct in an amount effective to prevent accelerated atherosclerosis in the subject. The present invention also provides for a method to prevent a macrovessel disease in a subject predisposed thereto which comprises administering to the subject a polypeptide derived from soluble receptor for advanced glycation endproduct in an amount effective to prevent macrovessel disease in the subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.